Related meta-analysis [73–75] had shown that DC-CIK could increase the CD3+ T cells, CD3+ CD4+ T cells, and the ratio of CD4+/CD8+ T cells in peripheral blood of patients with hepatocellular carcinoma (HCC) or gastric cancer. Here, CD8A is linked to gastric cancer.